Clinical Cancer Research Meeting Calendar Metabolism
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jokilehto, T.
Right arrow Articles by Jaakkola, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jokilehto, T.
Right arrow Articles by Jaakkola, P. M.
Clinical Cancer Research Vol. 12, 1080-1087, February 2006
© 2006 American Association for Cancer Research


Human Cancer Biology

Overexpression and Nuclear Translocation of Hypoxia-Inducible Factor Prolyl Hydroxylase PHD2 in Head and Neck Squamous Cell Carcinoma Is Associated with Tumor Aggressiveness

Terhi Jokilehto1,2,3, Krista Rantanen1,2, Marjaana Luukkaa4, Pekka Heikkinen1,2, Reidar Grenman5,6, Heikki Minn4, Pauliina Kronqvist7 and Panu M. Jaakkola1,2

Authors' Affiliations: 1 Turku Centre for Biotechnology, Turku University, 2 Åbo Akademi University, 3 Turku Graduate School of Biomedical Sciences, Departments of 4 Oncology and Radiotherapy, 5 Otorhinolaryngology-Head and Neck Surgery, 6 Medical Biochemistry, and 7 Pathology, Turku University and Turku University Hospital, Turku, Finland

Requests for reprints: Panu M. Jaakkola, Turku Centre for Biotechnology, Tykistökatu 6B, FIN-20520, Turku, Finland. Phone: 358-2333-8030; Fax: 358-2333-8000; E-mail: panjaa{at}utu.fi.

Purpose: Hypoxia in tumors is associated with poor prognosis and resistance to treatment. The outcome of hypoxia is largely regulated by the hypoxia-inducible factors (HIF-1{alpha} and HIF-2{alpha}). HIFs in turn are negatively regulated by a family of prolyl hydroxylases (PHD1-3). The PHD2 isoform is the main down-regulator of HIFs in normoxia and mild hypoxia. This study was designed to analyze the correlation of the expression and subcellular localization of PHD2 with the pathologic features of human carcinomas and HIF-1{alpha} expression.

Experimental Design: The expression of PHD2 was studied from paraffin-embedded normal tissue (n = 21) and head and neck squamous cell carcinoma (HNSCC; n = 44) by immunohistochemistry. Further studies included PHD2 mRNA detection and HIF-1{alpha} immunohistochemistry from HNSCC specimens as well as PHD2 immunocytochemistry from HNSCC-derived cell lines.

Results: In noncancerous tissue, PHD2 is robustly expressed by endothelial cells. In epithelium, the basal proliferating layer also shows strong expression, whereas the more differentiated epithelium shows little or no PHD2 expression. In HNSCC, PHD2 shows strongly elevated expression both at the mRNA and protein level. Moreover, PHD2 expression increases in less differentiated phenotypes and partially relocalizes from the cytoplasm into the nucleus. Endogenously high nuclear PHD2 is seen in a subset of HNSCC-derived cell lines. Finally, although most of the tumor regions with high PHD2 expression show down-regulated HIF-1{alpha}, regions with simultaneous HIF-1{alpha} and PHD2 expression could be detected.

Conclusions: Our results show that increased levels and nuclear translocation of the cellular oxygen sensor, PHD2, are associated with less differentiated and strongly proliferating tumors. Furthermore, they imply that even the elevated PHD2 levels are not sufficient to down-regulate HIF-1{alpha} in some tumors.




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
U. Berchner-Pfannschmidt, S. Tug, B. Trinidad, F. Oehme, H. Yamac, C. Wotzlaw, I. Flamme, and J. Fandrey
Nuclear Oxygen Sensing: Induction of Endogenous Prolyl-hydroxylase 2 Activity by Hypoxia and Nitric Oxide
J. Biol. Chem., November 14, 2008; 283(46): 31745 - 31753.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Couvelard, L. Deschamps, V. Rebours, A. Sauvanet, K. Gatter, F. Pezzella, P. Ruszniewski, and P. Bedossa
Overexpression of the Oxygen Sensors PHD-1, PHD-2, PHD-3, and FIH Is Associated with Tumor Aggressiveness in Pancreatic Endocrine Tumors
Clin. Cancer Res., October 15, 2008; 14(20): 6634 - 6639.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
U. Berchner-Pfannschmidt, S. Frede, C. Wotzlaw, and J. Fandrey
Imaging of the hypoxia-inducible factor pathway: insights into oxygen sensing
Eur. Respir. J., July 1, 2008; 32(1): 210 - 217.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
K. Rantanen, J. Pursiheimo, H. Hogel, V. Himanen, E. Metzen, and P. M. Jaakkola
Prolyl Hydroxylase PHD3 Activates Oxygen-dependent Protein Aggregation
Mol. Biol. Cell, May 1, 2008; 19(5): 2231 - 2240.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
F. Kassie, L. B. Anderson, L. Higgins, Y. Pan, I. Matise, M. Negia, P. Upadhyaya, M. Wang, and S. S. Hecht
Chemopreventive agents modulate the protein expression profile of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone plus benzo[a]pyrene-induced lung tumors in A/J mice
Carcinogenesis, March 1, 2008; 29(3): 610 - 619.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Fandrey, T. A. Gorr, and M. Gassmann
Regulating cellular oxygen sensing by hydroxylation
Cardiovasc Res, September 1, 2006; 71(4): 642 - 651.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.